Research led by Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, involving hepatic pharmokinetics and pharmacodynamics was the first-place winner in the Buffalo Translational Consortium (BTC) 2017 Clinical Research Achievement Awards.
Medical students and residents at the Jacobs School of Medicine and Biomedical Sciences stand to benefit from a new partnership between UBMD Internal Medicine and Evergreen Health to care for patients with HIV and hepatitis C.
Mark D. Hicar, MD, PhD, assistant professor of pediatrics, has been awarded a five-year, $1.9 million grant from the National Institute of Allergy and Infectious Diseases to investigate why some people infected with the HIV virus do not develop AIDS.
The Department of Medicine’s Division of General Internal Medicine had a strong showing at the 2017 Society of General Internal Medicine (SGIM) annual meeting with 11 research posters and one oral presentation.
At the 2017 Medical Student Research Forum, aspiring physician-scientists showcased 46 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Ira J. Blader, PhD, professor of microbiology and immunology, is using new grant funding to build on prior research aiming to identify how the infection-causing parasite Toxoplasma gondii triggers seizures and other neurological complications in AIDS and cancer patients as well as fetuses.
Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, has received a $7 million grant to develop an effective way to treat drug users with the hepatitis C virus (HCV).
Aspiring physician-scientists showcased 38 original research projects at the 2016 Medical Student Research Forum. The displays showed work they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Amy Jacobs, PhD, assistant professor of microbiology and immunology, received an award from the National Science Foundation to focus on the entry mechanism of the Ebola virus. The mechanism could be used to deliver drugs to infected cells.
Although measles was declared eliminated in the United States 15 years ago, recent outbreaks are spurring medical educators — including those at the University at Buffalo — to place a stronger emphasis on the disease in their lectures and clinical training.
At the 2015 Medical Student Research Forum, aspiring physician-scientists showcased 45 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Alan J. Lesse, MD, and John A. Sellick Jr., DO, associate professors of medicine in the Division of Infectious Diseases, presented the latest information about the Ebola virus outbreak at a Mini Medical School lecture, a free public talk.
“We have no reason to fear Ebola here in the United States, but the situation in West Africa is a grave humanitarian crisis,” Myron L. Glick, MD, told a standing room-only crowd of University at Buffalo medical students and residents shortly after returning from Sierra Leone.
University at Buffalo experts in the Division of Gastroenterology, Hepatology and Nutrition are contributing co-authors of HCV Next, the first multidisciplinary publication focused exclusively on the hepatitis C virus.